lazertinib,amivantamab-vmjw,osimertinib,niraparib
oscotec,gsk,yuhan corp,astrazeneca,genmab,janssen
['lcsm,(-blcsm)', 'lazertinib', 'import', 'sclc', 'nsclc', 'magnitude', 'chrysalis-2']
#asco22 #lcsm
imo, the most important data of the #lcsm morning , by : chrysalis-2 trial the combo of amivantamab plus lazertinib showed a magnitude of benefit in *heavily pretreated* pts with egfr-mutant nsclc, w/ or w/out brain mets! 
Thoracic oncologist & researcher @IEOufficiale; @myESMO Press & Media Chair; #LungCancer Molecular target-believer #LCSM